Atlas Trials

HC010 in First-line PD-L1 Positive Advanced NSCLC Patients

Clinical trial NCT07169552 · RECRUITING

Trial details

NCT number
NCT07169552
Sponsor
HC Biopharma Inc.
Status
RECRUITING
Phase
Phase 2
Study type
INTERVENTIONAL
NSCLC
Start date
2025-12-09
Primary completion
2026-12-30
Enrollment
50

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.